Technology | Computed Tomography (CT) | October 09, 2017

Coronary plaque burden analysis software now offers enhanced access to CT angiography studies across the network, ability to analyze multiple vessels at the same time

Medis Releases QAngio CT v3.1

October 9, 2017 — Medis has released a new version of its QAngio CT (computed tomography), which can now be launched from the Medis Suite imaging platform. QAngio CT v3.1 provides a detailed plaque burden analysis of the coronary system with comprehensive results.

Features of QAngio CT include:

Data import

  • Support for CT angiography (CTA) studies of all major CT vendors;
  • Access to CTA studies across the network;
  • Import of CTA studies from local storage media (hard disk, USB and CD/DVD);
  • DICOM connectivity, receiving cases, and query and retrieve;
  • Centralized database, thick client solution possible with multiple clients;
  • Loading of prior exams in parallel.

 Viewing

  • Viewing 3-D CTA series, double oblique viewing, MPR, MIP, slabbed MIP, VR; and
  • Efficient caliper measurements.

CTA analysis workflow

  • Fully automatic extraction of the complete coronary tree;
  • Semi-automatic editing of coronary tree;
  • Automatic labeling of the segments in the coronary tree with anatomical names;
  • Analyze multiple vessels at the same time;
  • A two-step contour detection approach per vessel for both lumen and vessel contours:
    • Longitudinal detection: provides quick overview of border and allows easy corrections which will propagate to the transversal step.
    • Transversal detection: Based on the longitudinal contours and corrections.
    • Edit contours in longitudinal and transversal images simultaneously; and
  • Flexible lesion detection and definition using synchronized views of the vessel data (stretched MPR, curved MPR, graphs).
    • Simple contour editing workflow (two steps)
    • Automatic segment labeling for reporting and statistics

CTA analysis results

  • Lumen and plaque statistics:
    • Degree of stenosis (diameter and area)
    • Lesion length
    • Plaque burden
    • Plaque volume (per lesion and per vessel)
    • Vessel remodeling index
    • Mean plaque and lumen intensities
  • Fixed and adaptive thresholding methods for plaque characterization;
  • Plaque characterization components according to Virtual Histology classification; and
  • Vessel segment labeling.

Data export

  • All analysis results including coronary tree, contours, lesion parameters and vessel labels can be saved and reloaded again for reviewing and/or exporting;
  • Easy data export for quantification data (Excel or copy-to-clipboard);
  • Batch processing of quantified parameters from multiple studies into a single spreadsheet
    • Segment based
    • Lesion based
    • Slice based; and
  • Screenshots (jpeg, png, copy to clipboard, DICOM snapshots).

 For more information: www.medis.nl


Related Content

News | FDA

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...

Time April 20, 2026
arrow
News | Radiology Imaging

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...

Time April 09, 2026
arrow
News | SNMMI

The Society of Nuclear Medicine and Molecular Imaging's (SNMMI) 2026 Annual Meeting will take place May 30–June 2 in Los ...

Time April 07, 2026
arrow
News | Radiology Business

March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...

Time March 31, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Cardiac Imaging

March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Time March 30, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 25, 2026 A Penn Medicine–led team has developed a first‑of‑its‑kind artificial intelligence system that interprets ...

Time March 26, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
News | Radiology Imaging

March 23, 2026 — Samsung Medison hsa announced that its U.S. medical imaging businesses, previously operating as ...

Time March 23, 2026
arrow
News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
Subscribe Now